Roy Peter Jonebrant

Roy Peter Jonebrant

Director/Board Member at PEXA AB

68 year
Health Technology
Finance
Electronic Technology

Profile

Roy Peter Jonebrant is currently the Chief Executive Officer at GOKAP Invest AB, CEO at GOKAP Invest, Director at Pexa AB, and Director at Jonebrant Ekonomikonsult AB.
He has previously worked as a Director at Emotra AB, Chief Financial Officer at Ascenditur AB, Chief Financial Officer at Biolin Scientific AB, Chief Financial Officer & Executive Vice President at Saxlund Group AB, Chief Financial Officer at Harm Reduction Group AB, Chief Financial Officer at Mediteam AB, and Chief Financial Officer at Biolight AB.

Roy Peter Jonebrant active positions

CompaniesPositionStart
PEXA AB Director/Board Member 2017-12-31
Jonebrant Ekonomikonsult AB Director/Board Member 1994-12-27
Chief Executive Officer 2007-04-30
Chief Executive Officer -
All active positions of Roy Peter Jonebrant

Former positions of Roy Peter Jonebrant

CompaniesPositionEnd
ISOFOL MEDICAL AB Director of Finance/CFO 2024-01-09
HARM REDUCTION GROUP AB Director of Finance/CFO 2021-12-31
Biolight AB Director of Finance/CFO -
Mediteam AB Director of Finance/CFO -
Director of Finance/CFO -
See the detail of Roy Peter Jonebrant's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Roy Peter Jonebrant's experience

Connections

30

1st degree connections

12

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies4
HARM REDUCTION GROUP AB

Electronic Technology

SAXLUND GROUP AB

Producer Manufacturing

PEXA AB

Health Technology

ISOFOL MEDICAL AB

Health Technology

Private companies8

Health Technology

Jonebrant Ekonomikonsult AB

Health Technology

Health Technology

Finance

Mediteam AB

Finance

Biolight AB

See company connections
  1. Stock Market
  2. Insiders
  3. Roy Peter Jonebrant
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW